New York, April 30, 2024 - PRISM MarketView - Cannabis stocks took off on recent news announced by the US government that marijuana will be reclassified to a Schedule III substance an equivalent to Tylenol with codeine, anabolic steroids and testosterone. For more than 50 years, marijuana had been a Schedule I substance alongside heroin and methamphetamines. The DEA’s proposal still needs to be reviewed by the White House Office of Management and Budget. Once the OMB has approved, the DEA will take public comment on its plan to reschedule.
While the market has otherwise been down, pot stocks are climbing as PRISM Emerging Cannabis Index companies are making green gains on the day. Canopy Growth (CGC) leads the index up over 60% as Leafly Holdings (LFLY), Tilray Brands (TLRY) and Trulieve (TCNNF) are up between 30% – 50%.
About PRISM MarketView
Established in 2020, PRISM MarketView is dedicated to the monitoring and analysis of small cap stocks in burgeoning sectors. We deliver up-to-the-minute financial market news, provide comprehensive investor tools and foster a dynamic investor community. Central to our offerings are proprietary indexes that observe emerging sectors, including biotech, clean energy, next-generation tech, medical devices and beyond. Visit us at prismmarketview.com and follow us on Twitter.
Disclaimer:
PRISM MarketView is not a registered or licensed broker-dealer or investment adviser and does not offer investment advice. The information provided in this communication is not intended to constitute an offer to sell, a solicitation of an offer to buy, or a recommendation for any security.
Contact:
Prism MarketView | Stock Market News & Investment Opportunities
PRISM MarketView - Social Media (X)